Medical Research

The National Medical Commission has asserted that the de-notification of the Maintenance of Standards of Medical Education Regulations, 2023 will not dilute prescribed standards of medical education and are intended to remove overlapping procedures. The Commission, which is the statutory body for medical education in the country, had on October 14 denotified the Maintenance of Standards of Medical Education Regulations (MSMER-2023). The denotification "does not, in any manner, dilute the prescribed standards of medical education or the regulatory oversight exercised by NMC," a statement by the Commission said. Under the National Medical Commission Act, 2019, the Undergraduate Medical Education Board (UGMEB) and Postgraduate Medical Education Board (PGMEB) are primarily entrusted with prescribing academic standards, minimum requirements and educational norms. The Medical Assessment and Rating Board (MARB), under Section 26 of the Act is specifically empowered to assess and inspect .

Union Minister Jitendra Singh on Saturday said India is poised to globally lead the next generation of medical practices, with the country making rapid advances across the life sciences and emerging areas of medical research and technology. Describing the present phase as an exciting time for medicine, the minister of state in the prime ministers office said the emergence of new technologies is opening up new possibilities in healthcare, but the challenge would be to achieve an optimum synergy between technology-driven practices and clinical medicine. He said the future of medical practice would require an optimum synergy between technology-driven practices and clinical medicine, with Artificial Intelligence (AI), genomics, quantum technologies and other emerging technologies opening new frontiers in healthcare. Addressing the first Aarogya Shikhar Samman A Medical Investiture Ceremony organised by the Jammu and Kashmir Chapter of the International Medical Sciences Academy (IMSA) .

An experimental one-time gene editing therapy significantly lowered LDL cholesterol in an early-stage trial, raising hopes for long-term heart disease prevention after a single infusion

An audit of 2.5 million biomedical research papers has revealed that nearly 3,000 contained fake citations absent in scientific databases, highlighting an alarming trend in academic publishing as the use of artificial intelligence (AI) grows. The papers were published between January 1, 2023, and February 18, 2026, in PubMed Central's Open Access database, managed by the US' National Institutes of Health. The findings, published in a correspondence article in The Lancet journal, also showed that among 97.1 million verified references, researchers identified 4,046 fake citations across 2,810 papers -- a more than 12-fold growth since 2023, with the sharpest increase beginning mid-2024, coinciding with the rise of AI writing tools. "This discovery directly impacts patients as medical professionals make treatment decisions based on clinical guidelines," lead researcher Maxim Topaz, associate professor at Columbia University's school of nursing and data science institute, said. "A medi

Just because a study reports a finding does not mean it applies to you; doctors explain how to interpret research, avoid misleading claims, and make better health decisions

The new ICMR directive pushes for Indian-centric medical research, recognising genetic, dietary and environmental differences in disease patterns

Uttarakhand HC allows Akash Yadav to resume duties at Indian Immunologicals Ltd, citing his essential role in national vaccine development; suspends his conviction in wife's abetment to suicide case

The goal of the study is "to address fundamental questions that will allow the development of a Smart Bionic Eye," according to an online description

AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths globally

The Esthetic Clinics and QR678 Research collaborate on groundbreaking research mapping hair growth pathways, potentially offering a non-surgical solution to hair restoration.

The breakthrough could prevent inherited diseases, but raises ethical concerns around access and genetic enhancement

With trust in science under scrutiny, a global initiative seeks to catch manipulated or inaccurate medical studies before they influence clinical or policy decisions

The cost of the test is 250 rupees, and the name of this kit is Loop-mediated isothermal amplification (LAMP) assay for rapid detection of Nipah virus

Post-birth diagnosis resulting in early treatment can substantially improve the quality of life and reduce mortality in patients with sickle cell disease to less than five per cent from the reported 20-30 per cent, according to an ICMR study. As many as 63,536 newborns were tested over a five year period from 2019- 2024 as part of the study on Newborn Screening for Sickle cell Disease conducted by the National Institute of Immunohaematology in Mumbai under the India Council of Medical Research (ICMR) across seven centres in high prevalence areas of India. The study is yet to be published. The newborn screening program helps find out if a baby is born with Sickle Cell Disease (SCD), a serious inherited blood disorder, soon after birth, explained Dr Manisha Madkaikar, Director of ICMR- Centre for Research Management and Control of Haemoglobinopathies (CRHCM) in Nagpur. "If not detected early, this disease can cause life-threatening problems like severe infections, anaemia (low blood

Morepen Laboratories on Friday said it will add more than 1,000 medical representatives over the next three years, with over 200 team members expected to join in FY26 alone. The company aims to strengthen its formulations business in the market through new hirings. "This expansion represents a pivotal moment in Morepen's journey as we sharpen our focus on the expanding domestic finished dosage market," Morepen Laboratories Chairman and MD Sushil Suri said in a statement. With significant increase in the sales force and enhanced reach to doctors, pharmacies, and patients, the drugmaker is setting the stage for getting a bigger pie in the Indian pharmaceutical market valued at Rs 2.38 lakh crore, yielding higher gross margins and better returns for stakeholders in the long run, he added. Currently, Morepen's formulation business stands around Rs 325 crore, and the company is targeting to touch Rs 1,000 crore in the next five years. This goal will be supported by an aggressive expans

Indian Institute of Technology (IIT), Madras on Monday launched a first-of-its-kind cancer genome database to help research on the disease in the country. According to IIT Madras Director, V Kamakoti, despite having a high cancer incidence, India has been under-represented in global cancer genome studies. In the absence of genomic architecture of cancers prevalent in India, specific genetic variants from Indian cancers are not adequately captured and catalogued for any diagnostic kits and drug development. "In order to fill the gap in the genomic landscape for different cancers in India, IIT Madras initiated the cancer genome programme in 2020. Under this programme, 960 whole exome sequencing from 480 breast cancer patient tissue samples collected across the country has been completed. "We are releasing yet another health-related data, the second this academic year, the cancer genome data after brain data. We hope that this will provide deep insights on reasons leading to this dead

The Research was led by the Institute's Centre of Excellence on Cancer Genomics and Molecular Therapeutics, which was funded under the Government of India's 'Institutions of Eminence' initiative

The Trump administration is drafting an executive order to temporarily halt federal funding for certain 'gain-of-function' virus research, although some pathogens, like H5N1, may be exempt from this

The ICMR has proposed a revised version of the National Essential Diagnostics List (NEDL), which enumerates the minimum number of tests that should be available at various levels of healthcare facilities in the country. According to the revised draft, nine types of diagnostic tests, including those for diabetes, Malaria, TB, HIV and syphilis should be made available at the health centres in village-level health facilities. Ayushman Arogya Mandirs should have facilities for Hepatitis B tests available in addition to the nine diagnostics that are available at the village-level health centres. The revised draft list has been prepared incorporating inputs from relevant stakeholders and feedback from multiple consultation meetings. It builds upon the first list and provides recommendations for diagnostic tests across various levels of healthcare facilities, including village-level facilities, Ayushman Arogya Mandirs, primary health centre (PHCs), community health centres (CHCs), sub ...

Humanity is hitting the upper limit of life expectancy, according to a new study. Advances in medical technology and genetic research not to mention larger numbers of people making it to age 100 are not not translating into marked jumps in lifespan overall, according to researchers who found shrinking longevity increases in countries with the longest-living populations. We have to recognise there's a limit and perhaps reassess assumptions about when people should retire and how much money they'll need to live out their lives, said S. Jay Olshansky, a University of Illinois-Chicago researcher who was lead author of the study published Monday by the journal Nature Aging. Mark Hayward, a University of Texas researcher not involved in the study, called it a valuable addition to the mortality literature. "We are reaching a plateau" in life expectancy, he agreed. It's always possible some breakthrough could push survival to greater heights, but we don't have that now, Hayward said. Wh